Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment—a grossly underestimated risk?-Reference-Cited by-同舟云学术

Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment—a grossly underestimated risk?

Published:2012-11-01 Issue:8 Volume:17 Page:1829-1837
ISSN:1432-6981
Container-title:Clinical Oral Investigations
language:en
Short-container-title:Clin Oral Invest

Author:

Hansen Peter Johannes,Knitschke Michael,Draenert Florian Guy,Irle Sebastian,Neff Andreas

Publisher

Springer Science and Business Media LLC

Subject

General Dentistry

Link

http://link.springer.com/content/pdf/10.1007/s00784-012-0873-3.pdf

Reference39 articles.

1. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117

2. Schwabe U, Ziegler R (2011) Osteoporosemittel. In: Arzneimittelverordnungsreport 2010. Springer, Berlin, pp 739–752

3. Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353(1):99–102

4. Dimopoulos MA et al (2006) Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 91(7):968–971

5. Bamias A et al (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23(34):8580–8587

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment;Osteoporosis International;2024-05-20

2. Cellular viability of fibroblasts, osteoblasts and osteoclasts in response to bone adhesive alendronate-functionalized poly(2-oxazoline);Polymer Testing;2024-02

3. Semaphorin 4D Promotes Osteoclast Formation but Inhibits Osteoblast Formation: Implication in Bisphosphonate-Related Osteonecrosis of the Jaw;Pharmacology;2023

4. Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database;Frontiers in Pharmacology;2022-10-19

5. Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort;Dentistry Journal;2022-05-19